Environmental Monitoring of Celecoxib, Ketoprofen, and Meloxicam in Pharmaceutical Wastewater by SPE-Assisted Micellar Electrokinetic Chromatography

The continuous discharge of pharmaceutical residues into aquatic environments has raised significant environmental concerns due to their persistence and incomplete removal during wastewater treatment. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most frequently detected pharmaceutical contaminants in industrial effluents. In this study, a sensitive and selective analytical method was developed for the simultaneous determination of ketoprofen (KTP), meloxicam (MEL), and celecoxib (CEL) in pharmaceutical wastewater using micellar electrokinetic chromatography (MEKC) combined with off-line solid-phase extraction (SPE). A high-volume SPE procedure (1000 mL sample) followed by evaporation and reconstitution provided a theoretical enrichment factor of approximately 10,000. Under optimised conditions, complete separation was achieved in less than 10 min. The method exhibited excellent linearity over a range of 0.5–20 µg/mL (r2 > 0.999), with limits of detection in wastewater ranging from 14 to 18 ng/L. Accuracy and precision complied with ICH Q2(B) guidelines, and recoveries from spiked wastewater samples ranged from approximately 99% to 101%, indicating efficient extraction and minimal analyte loss. The validated method was successfully applied to real pharmaceutical wastewater samples, demonstrating its suitability for the routine monitoring of trace-level NSAIDs in complex industrial matrices.